High-grade glioneuronal tumor with an ARHGEF2–NTRK1 fusion gene

Molecularly defined diffuse leptomeningeal glioneuronal tumor (DLGNT) comprises two subgroups with distinct clinical and genetic features

(2018) Maximilian Y. Deng et al.   ACTA NEUROPATHOLOGICA

DNA methylation-based classification of central nervous system tumours

(2018) David Capper et al.   NATURE

Inhibiting TRK Proteins in Clinical Cancer Therapy

(2018) Allison Lange et al.   Cancers

Unusual high-grade features in pediatric diffuse leptomeningeal glioneuronal tumor: comparison with a typical low-grade example

(2017) Katherine E. Schwetye et al.   HUMAN PATHOLOGY

Prognostic impact of the 2016 WHO classification of diffuse gliomas in the French POLA cohort

(2016) Emeline Tabouret et al.   ACTA NEUROPATHOLOGICA

The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary

(2016) David N. Louis et al.   ACTA NEUROPATHOLOGICA

SLC44A1 – PRKCA fusion in papillary and rosette-forming glioneuronal tumors

(2016) Masaya Nagaishi et al.   JOURNAL OF CLINICAL NEUROSCIENCE

MYB-QKI rearrangements in angiocentric glioma drive tumorigenicity through a tripartite mechanism

(2016) Pratiti Bandopadhayay et al.   NATURE GENETICS

A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas

(2016) Hideyuki Arita et al.   Acta Neuropathologica Communications

Entrectinib: a potent new TRK, ROS1, and ALK inhibitor

(2015) Christian Rolfo et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Altiratinib Inhibits Tumor Growth, Invasion, Angiogenesis, and Microenvironment-Mediated Drug Resistance via Balanced Inhibition of MET, TIE2, and VEGFR2

(2015) B. D. Smith et al.   MOLECULAR CANCER THERAPEUTICS

Recurrent papillary glioneuronal tumor presenting as a ganglioglioma with theBRAFV600E mutation

(2015) Hiroyuki Momota et al.   NEUROPATHOLOGY

Significant blockade of multiple receptor tyrosine kinases by MGCD516 (Sitravatinib), a novel small molecule inhibitor, shows potent anti-tumor activity in preclinical models of sarcoma

(2015) Parag P. Patwardhan et al.   Oncotarget

The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma

(2014) Gang Wu et al.   NATURE GENETICS

Anchored multiplex PCR for targeted next-generation sequencing

(2014) Zongli Zheng et al.   NATURE MEDICINE

The landscape and therapeutic relevance of cancer-associated transcript fusions

(2014) K Yoshihara et al.   ONCOGENE

Upregulating mutations in the TERT promoter commonly occur in adult malignant gliomas and are strongly associated with total 1p19q loss

(2013) Hideyuki Arita et al.   ACTA NEUROPATHOLOGICA

Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer

(2013) Aria Vaishnavi et al.   NATURE MEDICINE

Crizotinib versus Chemotherapy in Advanced ALK-Positive Lung Cancer

(2013) Alice T. Shaw et al.   NEW ENGLAND JOURNAL OF MEDICINE

Long-term Seizure Control Outcomes After Resection of Gangliogliomas

(2012) Derek G. Southwell et al.   NEUROSURGERY

Tandem Duplication Producing a Novel OncogenicBRAFFusion Gene Defines the Majority of Pilocytic Astrocytomas

(2008) David T.W. Jones et al.   CANCER RESEARCH